Literature DB >> 28334244

Cognitive Screening Tests Versus Comprehensive Neuropsychological Test Batteries: A National Academy of Neuropsychology Education Paper†.

Tresa M Roebuck-Spencer1, Tannahill Glen2, Antonio E Puente3, Robert L Denney4, Ronald M Ruff5, Gayle Hostetter6, Kevin J Bianchini1.   

Abstract

The American Medical Association Current Procedural Panel developed a new billing code making behavioral health screening a reimbursable healthcare service. The use of computerized testing as a means for cognitive screening and brief cognitive testing is increasing at a rapid rate. The purpose of this education paper is to provide information to clinicians, healthcare administrators, and policy developers about the purpose, strengths, and limitations of cognitive screening tests versus comprehensive neuropsychological evaluations. Screening tests are generally brief and narrow in scope, they can be administered during a routine clinical visit, and they can be helpful for identifying individuals in need of more comprehensive assessment. Some screening tests can also be helpful for monitoring treatment outcomes. Comprehensive neuropsychological assessments are multidimensional in nature and used for purposes such as identifying primary and secondary diagnoses, determining the nature  and severity of a person's cognitive difficulties, determining functional limitations, and planning treatment and rehabilitation. Cognitive screening tests are expected to play an increasingly important role in identifying individuals with cognitive impairment and in determining which individuals should be referred for further neuropsychological assessment. However, limitations of existing cognitive screening tests are present and cognitive screening tests should not be used as a replacement for comprehensive neuropsychological testing.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Assessment; Childhood neurologic disorders; Elderly/Geriatrics/Aging; Mild cognitive impairment; Professional issues

Mesh:

Year:  2017        PMID: 28334244     DOI: 10.1093/arclin/acx021

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  24 in total

Review 1.  Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment.

Authors:  Ni Xu; Benjamin Huggon; Kate E A Saunders
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

2.  Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology.

Authors:  Ece Bayram; David G Coughlin; Irene Litvan
Journal:  Mov Disord       Date:  2022-05-09       Impact factor: 9.698

3.  The Need for a Specialized Neurocognitive Screen and Consistent Cognitive Impairment Criteria in Spinal Cord Injury: Analysis of the Suitability of the Neuropsychiatry Unit Cognitive Assessment Tool.

Authors:  Danielle Sandalic; Yvonne Tran; Ashley Craig; Mohit Arora; Ilaria Pozzato; Grahame Simpson; Bamini Gopinath; Jasbeer Kaur; Sachin Shetty; Gerard Weber; Lisa Benad; James W Middleton
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

4.  Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.

Authors:  Thuy T Koll; Amelia Nelson Sheese; Jessica Semin; Weston Ernst; Robin High; Tanya M Wildes; Alfred Fisher; Daniel L Murman
Journal:  J Geriatr Oncol       Date:  2019-12-09       Impact factor: 3.599

5.  Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.

Authors:  Rebecca L Olin; Caitrin Fretham; Marcelo C Pasquini; Mukta Arora; Vijaya R Bhatt; Benjamin Derman; Sergio A Giralt; Li-Wen Huang; Thuy Koll; Sang Mee Lee; Richard J Lin; Linda Pang; Uday R Popat; Daniel J Weisdorf; Andrew Artz
Journal:  Blood Adv       Date:  2020-06-23

6.  How impaired is too impaired? Exploring futile neuropsychological test patterns as a function of dementia severity and cognitive screening scores.

Authors:  Andrew M Kiselica; Ellen Johnson; Jared F Benge
Journal:  J Neuropsychol       Date:  2021-03-03       Impact factor: 2.864

7.  Biomarker Use for Dementia With Lewy Body Diagnosis: Survey of US Experts.

Authors:  Melissa J Armstrong; David J Irwin; James B Leverenz; Noheli Gamez; Angela Taylor; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Jan-Mar 01       Impact factor: 2.357

Review 8.  Clinical Neuropsychological Evaluation in Older Adults With Major Depressive Disorder.

Authors:  Shawn M McClintock; Lex Minto; David A Denney; K Chase Bailey; C Munro Cullum; Vonetta M Dotson
Journal:  Curr Psychiatry Rep       Date:  2021-07-13       Impact factor: 8.081

9.  American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Authors:  M R DeBaun; L C Jordan; A A King; J Schatz; E Vichinsky; C K Fox; R C McKinstry; P Telfer; M A Kraut; L Daraz; F J Kirkham; M H Murad
Journal:  Blood Adv       Date:  2020-04-28

10.  Incidence, gender influence, and neuropsychological predictors of all cause dementia in the Faroe Islands-the Faroese Septuagenarian cohort.

Authors:  Kimberly C Paul; Fróði Debes; Eina Eliasen; Pál Weihe; Maria Skaalum Petersen
Journal:  Aging Clin Exp Res       Date:  2020-03-23       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.